RUNX1 and leukemia: The transcription factor complex of AML1-ETO fusion protein, consisting of AML1-ETO, LMO2, LDB1 and LYL1, has recently been considered the key to leukemia maintenance and differentiation blocking, because knockout of this complex can delay leukemogenesis in mice [5].